These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 391342

  • 1. Controlled trial of trimipramine, monoamine oxidase inhibitors, and combined treatment in depressed outpatients.
    Young JP, Lader MH, Hughes WC.
    Br Med J; 1979 Nov 24; 2(6201):1315-7. PubMed ID: 391342
    [Abstract] [Full Text] [Related]

  • 2. MAOIs in the contemporary treatment of depression.
    Thase ME, Trivedi MH, Rush AJ.
    Neuropsychopharmacology; 1995 May 24; 12(3):185-219. PubMed ID: 7612154
    [Abstract] [Full Text] [Related]

  • 3. Combining tricyclic and monoamine oxidase inhibitor antidepressants.
    Spiker DG, Pugh DD.
    Arch Gen Psychiatry; 1976 Jul 24; 33(7):828-30. PubMed ID: 942286
    [Abstract] [Full Text] [Related]

  • 4. [Combination of tricyclic antidepressants and MAOI in the depressions].
    Abdala EN.
    Acta Psiquiatr Psicol Am Lat; 1975 Mar 24; 21(1):52-5. PubMed ID: 1163269
    [Abstract] [Full Text] [Related]

  • 5. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ, Masiar SJ.
    Ann Pharmacother; 1992 Mar 24; 26(3):337-8. PubMed ID: 1554951
    [Abstract] [Full Text] [Related]

  • 6. Combined use of tricyclic antidepressants and monoamine oxidase inhibitors.
    Lader M.
    J Clin Psychiatry; 1983 Sep 24; 44(9 Pt 2):20-4. PubMed ID: 6355073
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ, Shin M, McInnis MG, Bostwick JR.
    Pharmacotherapy; 2015 Apr 24; 35(4):433-49. PubMed ID: 25884531
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind controlled trial of amineptine versus trimipramine in depression.
    Vauterin C, Bazot M.
    Curr Med Res Opin; 1979 Apr 24; 6(2):101-6. PubMed ID: 380909
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of depression in Huntington's disease with monoamine oxidase inhibitors.
    Ford MF.
    Br J Psychiatry; 1986 Nov 24; 149():654-6. PubMed ID: 2949793
    [Abstract] [Full Text] [Related]

  • 16. Trimipramine in the treatment of depression: a comparison of single vs. divided dose administration.
    Smith R, Amin MM, Ban TA.
    Psychopharmacol Bull; 1978 Jan 24; 14(1):42-3. PubMed ID: 625537
    [No Abstract] [Full Text] [Related]

  • 17. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
    Ponto LB, Perry PJ, Liskow BI, Seaba HH.
    Am J Hosp Pharm; 1977 Sep 24; 34(9):954-61. PubMed ID: 333909
    [Abstract] [Full Text] [Related]

  • 18. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ, Stewart JW, Nunes EN, Quitkin FM.
    J Clin Psychiatry; 1994 Aug 24; 55(8):336-9. PubMed ID: 8071301
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN, Brown BJ.
    Ann Pharmacother; 2006 Mar 24; 40(3):567-70. PubMed ID: 16478812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.